Paul Eisenberg

Paul Eisenberg, M.D., M.P.H. has over 30 years of drug development experience across therapeutic areas. He trained in Internal Medicine, Cardiology, and Pulmonary at Washington University and joined the faculty of the Department of Medicine where he led both basic and clinical research teams. He was appointed Professor of Medicine and also was the Director of the Cardiac Intensive Care Unit at Barnes-Jewish Hospital. Dr. Eisenberg joined Lilly in 1998 in Cardiovascular Discovery and, subsequently, was VP of General Medicine, and then Drug Safety. In 2005 he joined Amgen where he was SVP of Global Regulatory and Safety, and in 2014 became SVP of Global Medical and Chief Medical Officer. In March 2019 he joined Apple Tree Partners as Venture Partner.